The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 05, 2022

Filed:

May. 20, 2021
Applicant:

Daiichi Sankyo Company, Limited, Tokyo, JP;

Inventors:

Daisuke Nishimiya, Sumida-ku, JP;

Hidenori Yano, Ota-ku, JP;

Hidenori Takahashi, Ota-ku, JP;

Shinji Yamaguchi, Shinagawa-ku, JP;

Shiho Ofuchi, Shinagawa-ku, JP;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/57 (2006.01); C07K 14/81 (2006.01); C07K 19/00 (2006.01); A61K 38/55 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/81 (2013.01); A61K 38/55 (2013.01); A61K 38/57 (2013.01); C07K 14/811 (2013.01); C07K 14/8135 (2013.01); A61K 38/00 (2013.01); C07K 2319/30 (2013.01);
Abstract

SPINK2 mutant peptide conjugates are provided that inhibit KLK5. The KLK5 inhibitory peptide conjugates are Fc fusion peptides in which, in certain embodiments, the Fc region of the fusion peptides are the Fc region of human IgG1 or a fragment thereof. The KLK5 inhibitory peptide conjugates include an amino acid sequence of one of SEQ ID NOs: 34, 36, 38, 40, 42, 44, 46, 48, 96, 50, 52, 54, 56, 58, or 60. Pharmaceutical compositions that include the KLK5 inhibitory peptide conjugates useful for treating KLK5-related diseases are also provided.


Find Patent Forward Citations

Loading…